Breaking Finance News

Zacks Investment Research upgraded Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) to Hold in a report released today.

Just yesterday Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) traded 0.00% even at $27.75. Sociedad Quimica y Minera de Chile (ADR)’s 50-day moving average is $28.17 and its two hundred day average is $25.53. With the last close up 9.71% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time. 464,987 shares of the stock were exchanged, down from an average trading volume of 623,703

Zacks Investment Research has upgraded Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM) to Hold in a report released on 11/29/2016.

See Chart Below

Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM)

Sociedad Quimica y Minera de Chile (ADR) has a 52 week low of $14.31 and a 52 week high of $30.06 with a P/E ratio of 35.59 The company’s market cap is currently $0.

About Sociedad Quimica y Minera de Chile (ADR) (NYSE:SQM)

Sociedad Quimica y Minera de Chile S.A. (SQM), is a producer of potassium nitrate and iodine. The Company produces specialty plant nutrients, iodine derivatives, lithium and its derivatives, potassium chloride, potassium sulfate and certain industrial chemicals. Its segments include specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services. Specialty plant nutrients are fertilizers that enable farmers to improve yields and the quality of certain crops. Industrial chemicals have a range of applications in chemical processes, such as the manufacturing of glass and industrial nitrates. Iodine and its derivatives are used in the X-ray contrast media and biocides industries, among others. Lithium and its derivatives are used in batteries, greases and frits for production of ceramics. Potassium chloride is a commodity fertilizer that is produced and sold by the Company across the world.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *